UK markets open in 6 hours 57 minutes

Target Healthcare REIT Limited (THRL.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
115.20-0.80 (-0.69%)
At close: 4:40PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 5589.3M
Enterprise value 3672.23M
Trailing P/E 16.94
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)12.20
Price/book (mrq)106.57
Enterprise value/revenue 313.92
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 36.42%
S&P500 52-week change 336.39%
52-week high 3120.40
52-week low 3102.20
50-day moving average 3116.11
200-day moving average 3114.46

Share statistics

Avg vol (3-month) 3710.6k
Avg vol (10-day) 3990.96k
Shares outstanding 5511.54M
Implied shares outstanding 6N/A
Float 445.69M
% held by insiders 10.03%
% held by institutions 156.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.07
Forward annual dividend yield 45.79%
Trailing annual dividend rate 30.07
Trailing annual dividend yield 30.06%
5-year average dividend yield 45.73
Payout ratio 499.41%
Dividend date 3N/A
Ex-dividend date 411 Feb 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin 63.94%
Operating margin (ttm)76.18%

Management effectiveness

Return on assets (ttm)3.48%
Return on equity (ttm)6.25%

Income statement

Revenue (ttm)48.3M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)19.30%
Gross profit (ttm)39M
EBITDA N/A
Net income avi to common (ttm)30.88M
Diluted EPS (ttm)6.80
Quarterly earnings growth (yoy)-4.50%

Balance sheet

Total cash (mrq)18.32M
Total cash per share (mrq)0.04
Total debt (mrq)159.87M
Total debt/equity (mrq)32.32
Current ratio (mrq)2.02
Book value per share (mrq)1.08

Cash flow statement

Operating cash flow (ttm)36.91M
Levered free cash flow (ttm)38.59M